SCHEMBL19743069

SCHEMBL19743069

O=c1occc2[nH]cnc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 5/20 0.40
PNP P00491 1/20 0.38
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
DYRK1A Q13627 2/20 0.36
EGLN1 Q9GZT9 1/20 0.36
CSNK2A2 P19784 1/20 0.36
RAB9A P51151 1/20 0.36
CSNK2B P67870 1/20 0.36
CSNK2A1 P68400 1/20 0.36
CSNK2A3 Q8NEV1 1/20 0.36
LMNA P02545 2/20 0.36
POLB P06746 1/20 0.35
MMP12 P39900 1/20 0.35
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.33
PRNP P04156 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1550252 0.76 KDM4E (0.31) PNPRAB9AKDM4EALDH1A1MAPT
SCHEMBL30623174 0.72 LMNA (0.40) PARP1PNPMEN1KMT2ADYRK1A
SCHEMBL217336 0.70
SCHEMBL11123356 0.67 PNP (0.53) PARP1PNPMEN1KMT2ADYRK1A
SCHEMBL8121267 0.63 DPP4 (0.42) PARP1PNPMEN1KMT2ADYRK1A
SCHEMBL5726226 0.63 BRD4 (0.41) PARP1PNPMEN1KMT2ALMNA
SCHEMBL16346591 0.63 MMP12 (0.41) PARP1MEN1KMT2ADYRK1AEGLN1
SCHEMBL7293963 0.63 EGLN1 (0.42) PARP1PNPMEN1KMT2AEGLN1
SCHEMBL1261706 0.63 PARP1 (0.55) PARP1MEN1KMT2ADYRK1ALMNA
SCHEMBL2059241 0.63 EGLN1 (0.45) PARP1MEN1KMT2ADYRK1AEGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233827-B1 ANTIBACTERIAL COMPOUNDS HAVING BROAD SPECTRUM OF ACTIVITY ACRAF (IT) 2020-07-08 EP disclosed
US-10221144-B2 Antibacterial compounds having broad spectrum of activity AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2019-03-05 US disclosed
US-20170369450-A1 ANTIBACTERIAL COMPOUNDS HAVING BROAD SPECTRUM OF ACTIVITY AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.P.A. (IT) 2017-12-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170369450-A1 ANTIBACTERIAL COMPOUNDS HAVING BROAD SPECTRUM OF ACTIVITY MRPL21, ABCG2, CLPP PARP1 2791/4885PNP 1336/4885MEN1 4179/4885
US-10221144-B2 Antibacterial compounds having broad spectrum of activity MRPL21, ABCG2, CLPP PARP1 2791/4885PNP 1336/4885MEN1 4179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.